摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pG3'pG | 33008-99-0

中文名称
——
中文别名
——
英文名称
pG3'pG
英文别名
pG3'p5'G;pGpG;5'-pGG-3';Guanylyl(3'->5')guanin;5'-phosphoguanylyl-(3'->5')-guanosine;guanylyl-(5'->3')-[5']guanylic acid;5'-O-phosphonoguanylyl-(3'->5')-guanosine;[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate
pG<sup>3'</sup>pG化学式
CAS
33008-99-0
化学式
C20H26N10O15P2
mdl
——
分子量
708.432
InChiKey
ZEHOHLFQOXAZHX-MHARETSRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    2.60±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -7.8
  • 重原子数:
    47
  • 可旋转键数:
    10
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    372
  • 氢给体数:
    10
  • 氢受体数:
    19

SDS

SDS:e323886685bf13b5c977ed73e74178e5
查看

制备方法与用途

5'-磷酸鸟苷基-(3',5')-鸟苷(PGPGPG)是在酶促环二胍酯(c-di-GMP)降解过程中产生的中间产物。这种物质可用于检测核酸的代谢过程。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    guanosine 5’-diphosphate P-imidazolide disodium salt 、 N,N-dimethylhexylamine bicarbonate 、 pG3'pG 在 zinc(II) chloride 作用下, 以 N,N-二甲基甲酰胺乙腈 为溶剂, 反应 16.0h, 以0.112 g的产率得到
    参考文献:
    名称:
    TRINUCLEOTIDE MRNA CAP ANALOGS
    摘要:
    本公开涉及盖帽类似物,可以导致高水平的盖帽效率和转录以及改善翻译效率。本公开还涉及用于制备盖帽类似物和使用含有这种类似物的mRNA物种的有用方法,以及包含新型盖帽类似物的试剂盒。
    公开号:
    US20190211368A1
  • 作为产物:
    描述:
    二(3',5')-环二鸟苷酸 在 recombinant His6-tagged Bacillus subtilis YybT84-659 protein 、 potassium chloride 、 三羟甲基氨基甲烷 作用下, 生成 pG3'pG
    参考文献:
    名称:
    YybT Is a Signaling Protein That Contains a Cyclic Dinucleotide Phosphodiesterase Domain and a GGDEF Domain with ATPase Activity
    摘要:
    The cyclic dinucleotide c-di-GMP synthesized by the diadenylate cyclase domain was recently discovered as a messenger molecule for signaling DNA breaks in Bacillus subtilis. By searching bacterial genomes, we identified a family of DHH/DHHA1 domain proteins (COG3387) that co-occur with a subset of the diadenylate cyclase domain proteins. Here we report that the B. subtilis protein YybT, a member of the COG3387 family proteins, exhibits phosphodiesterase activity toward cyclic dinucleotides. The DHH/DHHA1 domain hydrolyzes c-di-AMP and c-di-GMP to generate the linear dinucleotides 5'-pApA and 5'-pGpG. The data suggest that c-di-AMP could be the physiological substrate for YybT given the physiologically relevant Michaelis-Menten constant (K-m) and the presence of YybT family proteins in the bacteria lacking c-di-GMP signaling network. The bacterial regulator ppGpp was found to be a strong competitive inhibitor of the DHH/DHHA1 domain, suggesting that YybT is under tight control during stringent response. In addition, the atypical GGDEF domain of YybT exhibits unexpected ATPase activity, distinct from the common diguanylate cyclase activity for GGDEF domains. We further demonstrate the participation of YybT in DNA damage and acid resistance by characterizing the phenotypes of the Delta yybT mutant. The novel enzymatic activity and stress resistance together point toward a role for YybT in stress signaling and response.
    DOI:
    10.1074/jbc.m109.040238
点击查看最新优质反应信息

文献信息

  • Sequence- and Regioselectivity in the Montmorillonite-Catalyzed Synthesis of RNA
    作者:Shin Miyakawa、James P. Ferris
    DOI:10.1021/ja034328e
    日期:2003.7.1
    nucleotides (pN) with activated monomers (ImpN), the sequence- and regioselectivity was Pu(3')Py > Pu(3')Pu = Pu(2')Py > Pu(2')Pu. The 5'-pyrimidine initiated dimers formed less efficiently than the 5'-purine initiated dimers. Trimer formation was investigated by the synthesis of 8 dimers (pNpN) and measuring the yields of trimers formed in the reaction of each dimer with a mixture of equal molar amounts
    通过检查蒙脱石催化的 RNA 二聚体和三聚体形成中的序列和区域选择性,研究了催化在从活化单体形成有限数量的 RNA 中的可能作用。A 的反应性与 G 的相似,C 的反应性与 U 相当。但嘌呤核苷酸的反应性与嘧啶的反应性不同。在核苷酸 (pN) 与活化单体 (ImpN) 的反应中,序列和区域选择性为 Pu(3')Py > Pu(3')Pu = Pu(2')Py > Pu(2')Pu。5'-嘧啶引发的二聚体形成的效率低于 5'-嘌呤引发的二聚体。通过合成 8 个二聚体 (pNpN) 并测量每个二聚体与等摩尔量的四种活化单体的混合物的反应中形成的三聚体的产率来研究三聚体的形成。二聚体的反应性取决于连接到 RNA 3'-末端的核苷酸和磷酸二酯键的区域化学。提出了基于这些研究的规则来预测在蒙脱石催化反应中形成的 RNA 的序列和区域选择性。这些规则与等摩尔量的 ImpA 和 ImpC 反应形成的 2-5
  • Unique Catalysis and Regioselectivity Observed in the Poly(C)-Directed RNA Dimer Formation from 2-MeImpG:  Kinetic Analysis as a Function of Monomer and Polymer Concentration
    作者:Anastassia Kanavarioti、Eldon E. Baird、T. Brian Hurley、Julie A. Carruthers、Sumana Gangopadhyay
    DOI:10.1021/jo991216q
    日期:1999.10.1
    of dimerization, d[D]/dt in M h(-1), was determined using two independent methods. The first method is based on the approximation that at the onset of the reaction the substrate is consumed only via hydrolysis and dimerization, and thus elongation can be neglected. The second, more accurate, method exploits the assertion that every oligomer was once a 3'-5'-linked dimer. Hence the concentration of
    聚胞苷,聚(C),用作支架或模板,以指导和催化由鸟苷5'-磷酸2-甲基咪唑啉化物2-MeImpG合成长寡聚鸟苷酸酯。在不存在聚(C)的情况下,缓慢形成少量的三个异构体二聚体,即2'-5'-,3'-5'-和焦磷酸盐连接的。在存在主要以3'-5'键连接的聚(C)低聚物的情况下,可以快速且高产率地形成。产物分析表明,该低聚物是3'-5'连接的二聚体(简称D)的延伸产物。假定D是由两个2-MeImpG分子缓慢形成的(方案1),并且延伸较快,则二聚化的初始速率,使用两种独立的方法确定M h(-1)中的d [D] / dt。第一种方法基于以下近似值:在反应开始时,仅通过水解和二聚作用消耗底物,因此可以忽略延伸率。第二种更准确的方法是利用以下主张:每个低聚物都曾经是3'-5'连接的二聚体。因此,D的浓度是从低聚物产物的浓度间接获得的。这两种方法给出了可比的结果。在1.0 M NaCl,0.2 M MgCl(2)的存在下于pH
  • VACCINE COMPOSITION
    申请人:CureVac AG
    公开号:EP3310384A1
    公开(公告)日:2018-04-25
  • [EN] VACCINE COMPOSITION<br/>[FR] COMPOSITION DE VACCIN
    申请人:CUREVAC AG
    公开号:WO2016203025A1
    公开(公告)日:2016-12-22
    A composition or combination comprising at least a first immunogenic component and at least a second adjuvant component, wherein the first immunogenic component comprises at least one nucleic acid molecule encoding at least one epitope of at least one antigen, and wherein the second adjuvant component comprises at least one immune potentiator compound and/or at least one delivery system compound.
  • YybT Is a Signaling Protein That Contains a Cyclic Dinucleotide Phosphodiesterase Domain and a GGDEF Domain with ATPase Activity
    作者:Feng Rao、Rui Yin See、Dongwei Zhang、Delon Chengxu Toh、Qiang Ji、Zhao-Xun Liang
    DOI:10.1074/jbc.m109.040238
    日期:2010.1
    The cyclic dinucleotide c-di-GMP synthesized by the diadenylate cyclase domain was recently discovered as a messenger molecule for signaling DNA breaks in Bacillus subtilis. By searching bacterial genomes, we identified a family of DHH/DHHA1 domain proteins (COG3387) that co-occur with a subset of the diadenylate cyclase domain proteins. Here we report that the B. subtilis protein YybT, a member of the COG3387 family proteins, exhibits phosphodiesterase activity toward cyclic dinucleotides. The DHH/DHHA1 domain hydrolyzes c-di-AMP and c-di-GMP to generate the linear dinucleotides 5'-pApA and 5'-pGpG. The data suggest that c-di-AMP could be the physiological substrate for YybT given the physiologically relevant Michaelis-Menten constant (K-m) and the presence of YybT family proteins in the bacteria lacking c-di-GMP signaling network. The bacterial regulator ppGpp was found to be a strong competitive inhibitor of the DHH/DHHA1 domain, suggesting that YybT is under tight control during stringent response. In addition, the atypical GGDEF domain of YybT exhibits unexpected ATPase activity, distinct from the common diguanylate cyclase activity for GGDEF domains. We further demonstrate the participation of YybT in DNA damage and acid resistance by characterizing the phenotypes of the Delta yybT mutant. The novel enzymatic activity and stress resistance together point toward a role for YybT in stress signaling and response.
查看更多

同类化合物

鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮 5'-dCT 2'-deoxyadenylyl-(3',5')-thymidine ammonium salt d(GpT) [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-prop-2-ynoxyoxolan-2-yl]methyl hydrogen phosphate pA3'p5'U pG3'p5'U pG3'p5'C cytidylyl-(3'-5')-3'-amino-3'-deoxy-3'-L-phenylalanyl-N6,N6-dimethyladenosine adenylyl-(3',5')-guanosine deoxyadenosyl(5'-3')thymidine phosphate cAIMP N4-palmitoyl-2'-deoxycytidylyl-(3'->5')-5-fluoro-2'-deoxyuridine